amiclenomycin: antibiotic isolated from Streptomyces lavendulae subsp. amiclenomycini Okami; active against mycobacterium; activity reversed by biotin & desthiobiotin; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 99594 |
| MeSH ID | M0049082 |
| Synonym |
|---|
| amiclenomycin, brn 5525177 |
| (2s)-2-amino-4-(4-aminocyclohexa-2,5-dien-1-yl)butanoic acid |
| l-2-amino-4-(4'-amino-2',5'-cyclohexadienyl)butyric acid |
| amiclenomycin |
| 53696-70-1 |
| cyclohexadiene-1-butanoic acid, alpha,4-diamino- |
| nsc 246130 |
| DB02725 |
| 2-amino-4-(4-amino-cyclohexa-2,5-dienyl)-butyric acid |
| (2s)-2-amino-4-(trans-4-aminocyclohexa-2,5-dien-1-yl)butanoic acid |
| '2-amino-4-(4-amino-cyclohexa-2,5-dienyl)-butyric acid' |
| PD060014 |
| AKOS040745556 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.26) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (14.29%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||